Search

Your search keyword '"Biotechnology industry -- Marketing"' showing total 23 results
Start Over Descriptor "Biotechnology industry -- Marketing" Publisher mary ann liebert, inc.
23 results on '"Biotechnology industry -- Marketing"'

1. Broadening genetic tests into the consumer market

Author

Marusina, Kate

Subjects
Biotechnology industry -- Marketing, Biotechnology industry -- Services, Genetic screening -- Marketing, Genetic screening -- Methods, Genetic screening -- Growth, Company marketing practices, Company growth, Biotechnology industry, Business
Abstract

Over 1,000 genetic tests are now clinically available for the consumer market, and more companies are increasing their development efforts to introduce genetic testing to their services. Genetic testing can diagnose or predict diseases linked to genetic conditions. The various genetic testing services being offered and their marketing strategies are given.

Published
2007

2. Cobra builds on contract manufacturing skills

Author

Aldridge, Susan

Subjects
Cobra Biomanufacturing PLC -- Marketing, Biotechnology industry -- Marketing, Company marketing practices, Biotechnology industry, Business
Abstract

Cobra BioManufacturing operations are discussed.

Published
2003

5. DTC genomics & leading-edge ethics

Author

MacDonald, Chris

Subjects
deCODE genetics Inc. -- Services, deCODE genetics Inc. -- Marketing, 23andMe Inc. -- Services, 23andMe Inc. -- Marketing, Navigenics Inc. -- Services, Navigenics Inc. -- Marketing, Genomics -- Marketing, Genomics -- Services, Genomics -- Ethical aspects, Biotechnology industry -- Services, Biotechnology industry -- Marketing, Biotechnology industry -- Ethical aspects, Company marketing practices, Biotechnology industry, Business
Abstract

Biotech companies such as 23andMe, Navigenics and deCode have started marketing direct-to-consumer (DTC) personal genomics services, the first time the fruit of the biotechnology industry is marketed directly to the public. Personal genomics companies will have to answer key ethical issues regarding the services they offer. Ethical questions for DTC firms are presented.

Published
2009

6. Industry on target for a successful year

Author

Burrill, G. Steven

Subjects
Biotechnology industry -- Finance, Biotechnology industry -- Securities, Biotechnology industry -- Marketing, Company financing, Company securities, Company marketing practices, Biotechnology industry, Business
Abstract

The biotechnology industry in the last two months of 2007 is in good shape, and its Burrill Biotech Select Index is up by 17.5% since the start of the year. There is an increase in biotech initial public offerings (IPOs) throughout the year, and more are on their way. Trends in biotech funding and the shift to promoting wellness are discussed as well.

Published
2007

7. Making the complex simple

Author

Boudreau, Michele

Subjects
Biotechnology industry -- Management, Biotechnology industry -- Marketing, Drugs -- Marketing, Communication in medicine, Company business management, Company marketing practices, Biotechnology industry, Business
Abstract

The need for improving the marketing strategy of biotech companies by focusing on communicating the brand-positioning of a drug is discussed.

Published
2006

8. Metrics for economic development

Author

Ruff, Lorraine and Gabrilska, David A.

Subjects
Biotechnology industry -- Management, Biotechnology industry -- Marketing, Biotechnology industry -- Product development, Business success -- Planning, Company business management, Company marketing practices, Company business planning, Biotechnology industry, Business
Abstract

Need for biotechnology companies to devise a result-oriented marketing and product innovation plan to achieve business success, is discussed.

Published
2006

9. Prolume aglow with its genetic entertainment

Subjects
Prolume Ltd. -- Marketing, Biotechnology industry -- Marketing, Biotechnology industry, Business
Abstract

The article discusses the marketing tactics and technological advances of Prolume Ltd., a biotechnology company that uses bioluminescence in its technologies.

Published
2000

14. New Biotech treatment binds toxins from E. coli

Author

Pramik, Mary Jean

Subjects
Alberta. Alberta Research Council -- Research, Legacy Ability Products and Services Inc. -- Marketing, Food poisoning -- Care and treatment, Escherichia coli infections -- Care and treatment, Hemolytic-uremic syndrome -- Care and treatment, Biotechnology industry -- Marketing, Biotechnology industry, Business
Published
1993

18. Reining in new therapeutic hype is critical

Author

Feehan, Michael and Durante, Rich

Subjects
Biotechnology industry -- Officials and employees, Biotechnology industry -- Finance, Biotechnology industry -- Marketing, Executives -- Management, Product development -- Finance, Time to market, Company financing, Company marketing practices, Company business management, Biotechnology industry, Business
Abstract

Biotechnology industries executives should present investors with a realistic appraisal of risks and costs in product development. They should also present the market opportunities and challenges realistically. Biotechnology companies and investors need to consider in-market resistance among physicians to new vaccines.

Published
2008

19. Novozymes tackles ingredient manufacture

Author

Potera, Carol

Subjects
Novozymes North America Inc. -- Growth, Novozymes North America Inc. -- Product information, Novozymes North America Inc. -- Marketing, Biotechnology industry -- Growth, Biotechnology industry -- Product information, Biotechnology industry -- Marketing, Company growth, Company marketing practices, Product marketing strategy, Biotechnology industry, Business
Abstract

Industrial enzymes and microorganisms supplier Novozymes is growing its operations and moving into biopharmaceutical ingredients manufacturing. The company has reorganized to diversify its base, and has introduced various products such as recombinant proteins. Other expansion efforts of Novozymes and its involvement in biofuel production are discussed.

Published
2007

21. Sticky ends

Subjects
United States. Food and Drug Administration -- Powers and duties, United States. Department of Commerce -- Science and technology policy, Genentech Inc. -- Marketing, Cistron Biotechnology Inc. -- Cases, Immunex Corp. -- Cases, Synergy Research Corp. -- Finance, BioHybrid Technologies Inc. -- Finance, Graver Chemical Company Inc. -- Buildings and facilities, Chiros Ltd. -- Names, United States Filter Corp. -- Mergers, acquisitions and divestments, Ionpure Technologies Corp. -- Mergers, acquisitions and divestments, Bio-Technology General Corp. -- Intellectual property, Alkermes Inc. -- Intellectual property, Yellow Springs Instrument Inc. -- Management, Beckman Coulter Inc. -- Management, Affymax N.V. -- Intellectual property, Biotechnology industry -- Marketing, Patents -- Cases, Proteins -- Research, Peptides -- Intellectual property, Biotechnology industry, Business, Scripps Clinic and Research Foundation -- Research, Pulmozyme (Medication) -- Marketing
Published
1994

23. Schering-Plough Corp

Subjects
Schering-Plough Corp. -- Joint ventures, Genetics Institute Inc. -- Joint ventures, Biotechnology industry -- Marketing, Biotechnology industry, Business
Published
1991

Catalog

Books, media, physical & digital resources
See catalog results